Cube Row Bird · Morning Post (August 9)

Author:Dahe Cai Cube Time:2022.08.09

① Tong Juntang, a wholly -owned subsidiary of Taiolong Pharmaceutical, provides guarantees for its 70 million yuan bank credit;

② Due to serious violations of discipline and law, Li Wei, former party committee secretary and chairman of Yunnan Publishing Group Co., Ltd., is currently undergoing disciplinary review and supervision and investigation;

③ The operating income of Yuetai Co., Ltd. was 1.086 billion yuan in the first half of 2022, an increase of 308.48%year -on -year, and a net loss of 631 million yuan, the loss of losses year -on -year;

④ Due to the poor internal quality control of management asset support, the two leaders of Hengtai Securities were identified as inappropriate candidates by Inner Mongolia Securities Regulatory Bureau;

⑤ Because the information is not rigorous, Hanyu Pharmaceutical Collection of Deep Stock Exchange Supervisory letter;

⑥ The signing of the strategic cooperation framework agreement between Zhongji Group and Jingdong Group. The two parties will focus on cooperation around the fields of logistics technology equipment and services, material procurement, etc.

行 Wang Yulin, CEO of Jinshan Yun, resigned due to personal health. Zou Tao, vice chairman, served as the agent's CEO;

⑧ Due to the change of work, Wang Xifeng resigned as the executive director and president of Hengfeng Bank;

2 Yongxing Materials' revenue in the first half of 2022 was 6.414 billion yuan, an increase of 110.51%year -on -year; net profit of home mother was 2.263 billion yuan, an increase of 647.64%year -on -year;

卫 Fitch confirmed that the financial strength rating of Fuwei Insurance's insurance company was "BBB+", looking forward to "positive".

#Become a member of Cube Ratings Bird, Enjoy Live Version Risk Control Service#

Responsible editor: Tao Jiyan | Review: Li Zhen | Director: Wan Junwei

- END -

Cube Right Control Bird · Evening News (August 9)

① Pleoco's revenue of 513 million yuan in the first half of 2022, a year -on -yea...

Kelly Pharmaceutical's subsidiary Chuanning Biological GEM IPO has been approved by 600 million yuan to raise nearly 70 % for debt repayment

Red Star Capital August 14 news, Kelun Pharmaceutical (002422.SZ) announced that i...